Kaiser Permanente San Francisco — San Francisco, California

Kaiser Permanente San Francisco is a clinical research site located in San Francisco, California, United States.

Crixeo Clinical Trials Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Kaiser Permanente San Francisco has participated in 22 clinical trials with 12 currently active.

Therapeutic areas: Chronic Hepatitis B, Tricuspid Regurgitation, Tricuspid Valve Insufficiency.

Sponsors: Gilead Sciences, Edwards Lifesciences, Karyopharm Therapeutics Inc.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kaiser Permanente San Francisco?

Kaiser Permanente San Francisco has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kaiser Permanente San Francisco conducted?

Kaiser Permanente San Francisco has 22 clinical trials on record, with 12 currently active. Their work covers Chronic Hepatitis B, Tricuspid Regurgitation, Tricuspid Valve Insufficiency.

Is Kaiser Permanente San Francisco accredited by Crixeo Clinical Trials?

Kaiser Permanente San Francisco has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kaiser Permanente San Francisco?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.